Skip to content
Wenlo
Sign in
← Markets

Whitehawk Therapeutics, Inc.

Margaret Dugan (Chief Medical Officer) reports WHWK insider transactions

4/AWHWKFiled Sep 18, 2026, 12:40 PM ET· Period Sep 15, 2026

About this filing

Whitehawk Therapeutics, Inc. (WHWK) filed Form 4/A (insider transaction (amendment)) with the SEC on Sep 18, 2026. Form 4 reports a company insider’s trades in the company’s shares.

View original filing on SEC.gov (opens SEC EDGAR)

Key facts

Insider
Margaret Dugan · Chief Medical Officer
DateTransactionSharesPriceValueHeld afterOwnership
Sep 15, 2026A · grantStock Option (right to buy)Footnotes F1+81,250$0.00$0.0081,250Direct
Sep 15, 2026A · grantRestricted Stock UnitsFootnotes F2, F3+81,250$0.00$0.0081,250Direct
Footnotes
  1. F1 Subject to the Reporting Person continuing to be a Service Provider (as defined in the Issuer's 2021 Equity Incentive Plan) through each applicable date, twenty five percent (25%) of the shares subject to the option shall vest on the one-year anniversary of the Vesting Commencement Date and 1/48th of the total shares subject to the option shall vest every month thereafter such that all shares subject to the option shall be fully vested on the four-year anniversary of the Vesting Commencement Date. "Vesting Commencement Date" shall mean September 15, 2026.
  2. F2 Each restricted stock unit ("RSU") represents a contingent right to receive one share of Whitehawk Therapeutics, Inc. Common Stock.
  3. F3 The original Form 4 filed by the Reporting Person erroneously reflected an incorrect vesting schedule. Subject to the Reporting Person continuing to be a Service Provider (as defined in the Issuer's 2021 Equity Incentive Plan) through the applicable date, one hundred percent (100%) of the shares subject to the award shall vest on the one-year anniversary of the Vesting Commencement Date. "Vesting Commencement Date" shall mean September 15, 2026.

More WHWK filings

Not investment advice. Summaries can contain errors; the SEC filing is the official record.